CLINICAL_TRIALS
trial_result
· 2015-04-08
Clinical Trial Update: Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days [Phase 2]
Summary
A Phase 2 trial evaluating empagliflozin added to insulin in adults with Type 1 diabetes mellitus over 28 days; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2015-04-08